Selecta Biosciences is a clinical-stage biopharmaceutical company developing targeted immunotherapies and vaccines that are designed to modulate immune responses to treat and prevent disease. Selecta’s proprietary Synthetic Vaccine Particle (SVP™) platform has the potential to create a new paradigm in immunology and may enable a novel approach for selectively targeting the immune system to effectively and safely treat and prevent rare and serious diseases.
View Top Employees from Selecta BiosciencesWebsite | https://www.selectabio.com |
Ticker | SELB |
Revenue | $903000 |
Funding | $257.5 million |
Employees | 29 (12 on RocketReach) |
Founded | 2008 |
Address | 65 Grove Street, Watertown, Massachusetts 02472, US |
Phone | (617) 923-1400 |
Fax | (617) 924-3454 |
Technologies |
JavaScript,
HTML,
PHP
+36 more
(view full list)
|
Industry | Biotechnology, Organizations, Education, Business Services, Biopharma, Drug Discovery, Health Care, Science and Engineering, Pharmaceutical |
Web Rank | 3 Million |
Keywords | Selecta Biosciences, Selecta, Selecta Cowen, Selecta Biosciences Inc, Biotech Companies In Massachusetts |
Competitors | GlycoMimetics, IRX Therapeutics, Inc., Inimmune, Precision Biologics, Qu Biologics Inc. |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 541 Companies, NAICS Code 3254 Companies |
Looking for a particular Selecta Biosciences employee's phone or email?
The Selecta Biosciences annual revenue was $903000 in 2023.
Kei Kishimoto is the Chief Scientific Officer of Selecta Biosciences.
12 people are employed at Selecta Biosciences.
Selecta Biosciences is based in Watertown, Massachusetts.
The NAICS codes for Selecta Biosciences are [54, 32, 325, 32541, 541, 3254].
The SIC codes for Selecta Biosciences are [87, 873].